Lobbying

Promedtek's latest lobbying report covers Q2 2026, at $40K. The four quarters Q4 2025–Q3 2026 total $120K. Its first report covers Q4 2022; the issues it reports most are Health Issues.

Promedtek

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$120K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Promedtek lobbying by quarter
Promedtek lobbying by quarter
QuarterAmountReports
Q4 2022$20K1
Q1 2023$20K1
Q2 2023$20K1
Q3 2023$20K1
Q4 2023$20K1
Q1 2024$20K1
Q2 2024$20K1
Q3 2024$20K1
Q4 2024$20K1
Q1 2025$20K1
Q2 2025$20K1
Q3 2025$20K1
Q4 2025$40K1
Q1 2026$40K1
Q2 2026$40K1
Q3 2026$00

By issue

  • Health issues$360K · 15 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Executive Office of the President (EOP)15 reports
  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports
  • Veterans Affairs, Dept of (VA)15 reports
  • Health & Human Services, Dept of (HHS)8 reports
  • Defense, Dept of (DOD)7 reports

Firms it paid

Firm
Bell & Lindsay$360K15 quarters

Former officials lobbying for it

Former position
MARK F LINDSAYUS House StaffQ2 2026

Lobbying reports

Filed by
07/20for Q2Bell & Lindsay$40K
04/20for Q1Bell & Lindsay$40K
01/20for Q4 2025Bell & Lindsay$40K
25/10/20for Q3 2025Bell & Lindsay$20K
25/07/21for Q2 2025Bell & Lindsay$20K
25/04/21for Q1 2025Bell & Lindsay$20K
25/01/21for Q4 2024Bell & Lindsay$20K
24/10/21for Q3 2024Bell & Lindsay$20K
24/07/19for Q2 2024Bell & Lindsay$20K
24/04/19for Q1 2024Bell & Lindsay$20K
24/01/19for Q4 2023Bell & Lindsay$20K
23/10/20for Q3 2023Bell & Lindsay$20K
23/07/20for Q2 2023Bell & Lindsay$20K
23/04/19for Q1 2023Bell & Lindsay$20K
23/01/19for Q4 2022Bell & Lindsay$20K